# | Title | Journal | Year | Citations |
---|
1 | Functional Recovery After Acute Myocardial Infarction | Journal of the American College of Cardiology | 2008 | 314 |
2 | Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial | Lancet, The | 2016 | 284 |
3 | A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients | Journal of the American College of Cardiology | 2012 | 229 |
4 | Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial | Lancet, The | 2016 | 208 |
5 | Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial | Lancet, The | 2020 | 205 |
6 | Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis | BMJ, The | 2013 | 194 |
7 | Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial | Lancet, The | 2014 | 171 |
8 | Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology | European Journal of Heart Failure | 2016 | 164 |
9 | Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI | Journal of the American College of Cardiology | 2020 | 154 |
10 | Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients withde novocoronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial | European Heart Journal | 2016 | 149 |
11 | Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries | Circulation | 2004 | 140 |
12 | Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial | Lancet, The | 2018 | 112 |
13 | Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions | Basic Research in Cardiology | 2008 | 86 |
14 | Intravascular Ultrasound for the Evaluation of Therapies Targeting Coronary Atherosclerosis | Journal of the American College of Cardiology | 2007 | 82 |
15 | High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo‐controlled pilot study | Catheterization and Cardiovascular Interventions | 2008 | 79 |
16 | Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study | Catheterization and Cardiovascular Interventions | 2018 | 75 |
17 | Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction | JAMA Cardiology | 2019 | 75 |
18 | The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy | Netherlands Heart Journal | 2009 | 68 |
19 | Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents | Journal of the American College of Cardiology | 2013 | 68 |
20 | Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data | European Heart Journal | 2021 | 68 |
21 | Coronary Angiography After Cardiac Arrest Without ST Segment Elevation | JAMA Cardiology | 2020 | 65 |
22 | Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial | Europace | 2020 | 64 |
23 | Tele‐guidance of chronic heart failure patients enhances knowledge about the disease. A multi‐centre, randomised controlled study | European Journal of Heart Failure | 2008 | 60 |
24 | Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation | Clinical Neurology and Neurosurgery | 2007 | 59 |
25 | Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels | JAMA Cardiology | 2019 | 56 |
26 | Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial | American Heart Journal | 2016 | 55 |
27 | In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris — DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial | International Journal of Cardiology | 2018 | 54 |
28 | Effect of outpatient exercise training programmes in patients with chronic heart failure: a systematic review | European Journal of Preventive Cardiology | 2012 | 49 |
29 | Fractional Flow Reserve and Coronary Bifurcation Anatomy | JACC: Cardiovascular Interventions | 2015 | 49 |
30 | Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries | Journal of the American College of Cardiology | 2006 | 47 |
31 | Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention | JACC: Cardiovascular Interventions | 2019 | 44 |
32 | Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents | JACC: Cardiovascular Interventions | 2019 | 44 |
33 | Resistant hypertension in patients with chronic aortic dissection | Journal of Human Hypertension | 2005 | 42 |
34 | Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients | JAMA Cardiology | 2017 | 42 |
35 | Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT | EuroIntervention | 2017 | 42 |
36 | Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents | JACC: Cardiovascular Interventions | 2015 | 41 |
37 | 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents | JACC: Cardiovascular Interventions | 2018 | 41 |
38 | Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment–Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel | Circulation | 2019 | 40 |
39 | Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris | Lancet, The | 1995 | 39 |
40 | Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents | American Heart Journal | 2016 | 39 |
41 | Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score | Europace | 2014 | 38 |
42 | Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial | EuroIntervention | 2018 | 38 |
43 | Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG) | Circulation | 2020 | 37 |
44 | The golden hour of prehospital reperfusion with triple antiplatelet therapy: A sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy | American Heart Journal | 2010 | 36 |
45 | Association of Psychiatric History and Type D Personality with Symptoms of Anxiety, Depression, and Health Status Prior to ICD Implantation | International Journal of Behavioral Medicine | 2013 | 35 |
46 | Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo | International Journal of Cardiovascular Imaging | 2009 | 34 |
47 | Spectrum of remodeling behavior observed with serial Long-Term (≥12 months) Follow-Up intravascular ultrasound studies in left main coronary arteries | American Journal of Cardiology | 2004 | 33 |
48 | Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction | Journal of Thrombosis and Haemostasis | 2009 | 33 |
49 | Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European Heart Rhythm Association and European Society of Cardiology Working Group on eCardiology in collaboration with the Heart Rhythm Society, Asia Pacific Heart Rhythm Society, Latin American Heart Rhythm Society and Computing in Cardiology | Europace | 2022 | 33 |
50 | Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction | European Heart Journal | 2019 | 32 |